399 related articles for article (PubMed ID: 9420238)
1. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
[TBL] [Abstract][Full Text] [Related]
2. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
[TBL] [Abstract][Full Text] [Related]
3. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines.
Dolei A; Biolchini A; Serra C; Curreli S; Gomes E; Dianzani F
AIDS; 1998 Jan; 12(2):183-90. PubMed ID: 9468367
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
Margolis LB; Glushakova S; Grivel JC; Murphy PM
J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
[TBL] [Abstract][Full Text] [Related]
5. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis.
Lin CL; Sewell AK; Gao GF; Whelan KT; Phillips RE; Austyn JM
J Exp Med; 2000 Aug; 192(4):587-94. PubMed ID: 10952729
[TBL] [Abstract][Full Text] [Related]
8. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
9. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
Alkhatib G; Combadiere C; Broder CC; Feng Y; Kennedy PE; Murphy PM; Berger EA
Science; 1996 Jun; 272(5270):1955-8. PubMed ID: 8658171
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
Capobianchi MR; Abbate I; Antonelli G; Turriziani O; Dolei A; Dianzani F
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):233-40. PubMed ID: 9491913
[TBL] [Abstract][Full Text] [Related]
11. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
12. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
[TBL] [Abstract][Full Text] [Related]
13. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
[TBL] [Abstract][Full Text] [Related]
15. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
[TBL] [Abstract][Full Text] [Related]
16. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
[TBL] [Abstract][Full Text] [Related]
17. Difference in susceptibility to CC-chemokines among HIV-1 isolates.
Gao M; Tsuchie H; Jin TQ; Zhang J; Detorio MA; Hossain MM; Taniguchi K; Kurimura T
Int J STD AIDS; 1998 Aug; 9(8):471-5. PubMed ID: 9702596
[TBL] [Abstract][Full Text] [Related]
18. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.
Moriuchi H; Moriuchi M; Combadiere C; Murphy PM; Fauci AS
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15341-5. PubMed ID: 8986813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]